<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04122573</url>
  </required_header>
  <id_info>
    <org_study_id>WestChinaH1</org_study_id>
    <nct_id>NCT04122573</nct_id>
  </id_info>
  <brief_title>Prospective Multicenter Study for Early Evaluation of Acute Chest Pain</brief_title>
  <acronym>PEACP</acronym>
  <official_title>Prospective Multicenter Study for Early Evaluation of Acute Chest Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>West China Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>West China Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, clinical database and blood sample bank of acute chest pain (ACP) will be
      established at chest pain center of multi-center hospital. To explore new biomarkers and
      screen clinical indicators with effective risk stratification and prognostic evaluation for
      ACP through proteomics technology and statistics methods. Risk stratification and short-term
      and long-term prognostic evaluation models for high-risk ACP will be established using large
      data analysis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, acute chest pain (ACP) patients will be selected from chest pain center of
      nine large tertiary hospitals in China from November 1, 2019 to October 31, 2021. All the
      selected patients will sign the informed consent.

      Patients' characteristics, the first vital signs at the time of consultation, the first
      arterial blood gas, complete blood count, coagulation markers, blood biochemical results and
      myocardial injury markers, imaging examinations and electrocardiogram will be collected
      within 30 minutes at admission. Meanwhile, whole blood and plasma samples will be collected
      and stored in - 80 â„ƒ refrigerator. After diagnosis according to the gold standard examination
      or related guidelines, patients will be admitted to different department for standard
      treatment. Medication, surgical procedures and complications will be recorded carefully.
      Plasma and whole blood will be used to detect proteomics and/or genomics biomarkers
      associated with early evaluation of ACP.

      Screening early evaluation indicators using novel protein biomarkers and easy-to-obtain
      clinical indicators, and establishing evaluation models for high-risk ACP by data analysis
      methods. Area under the receiver operating characteristic curves (AUROC), net
      reclassification improvement (NRI), integrated discrimination improvement (IDI) and decision
      curve analysis (DCA) will be used to evaluate the prediction ability of the model.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2019</start_date>
  <completion_date type="Anticipated">October 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Rate of participants with all-cause death</measure>
    <time_frame>One year</time_frame>
    <description>Patients die of all causes during hospitalization or follow-up</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of participants with cardiovascular death</measure>
    <time_frame>One year</time_frame>
    <description>Patients die of cardiac and cerebrovascular diseases during hospitalization or follow-up</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of participants with major adverse cardiac events (MACEs)</measure>
    <time_frame>One year</time_frame>
    <description>MACEs include cardiac death, stroke, and recurrent myocardial infarction.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of participants with acute myocardial infarction</measure>
    <time_frame>Twenty-four hours</time_frame>
    <description>Chest pain patients are diagnosed as acute myocardial infarction based on fourth edition of guidelines for myocardial infarction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of participants with acute pulmonary embolism</measure>
    <time_frame>Twenty-four hours</time_frame>
    <description>Chest pain patients are diagnosed as acute pulmonary embolism based on CT of pulmonary angiography.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of participants with acute aortic dissection</measure>
    <time_frame>Twenty-four hours</time_frame>
    <description>Chest pain patients are diagnosed as acute aortic dissection based on CT of aortic angiography.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of participants with acute coronary syndrome</measure>
    <time_frame>Twenty-four hours</time_frame>
    <description>Chest pain patients are diagnosed as acute coronary syndrome based on European Society of Cardiology (ESC) guidelines.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of participants with ischemia or necrosis of lower limbs</measure>
    <time_frame>Two weeks</time_frame>
    <description>Patients complicate with ischemia or necrosis of lower limbs during hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of participants with acute heart failure</measure>
    <time_frame>Two weeks</time_frame>
    <description>Patients complicate with acute heart failure during hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of participants with revascularization</measure>
    <time_frame>Two weeks</time_frame>
    <description>Patients receive revascularization for recurrent angina or myocardial infarction during hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of participants with consciousness disorder</measure>
    <time_frame>Two weeks</time_frame>
    <description>Patients complicate with consciousness disorder during hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of participants with cardiogenic shock</measure>
    <time_frame>Two weeks</time_frame>
    <description>Patients complicate with cardiogenic shock during hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of participants with acute kidney injury</measure>
    <time_frame>Two weeks</time_frame>
    <description>Patients complicate with acute kidney injury during hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of participants with malignant arrhythmia</measure>
    <time_frame>Two weeks</time_frame>
    <description>Patients complicate with malignant arrhythmia during hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of participants with pericardial tamponade</measure>
    <time_frame>Two weeks</time_frame>
    <description>Patients complicate with pericardial tamponade during hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of participants with bleeding</measure>
    <time_frame>One year</time_frame>
    <description>Patients complicate with bleeding</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of participants with multiple organ dysfunction syndrome</measure>
    <time_frame>Two weeks</time_frame>
    <description>Patients complicate with multiple organ dysfunction syndrome during hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of participants with respiratory failure</measure>
    <time_frame>Two weeks</time_frame>
    <description>Patients complicate with respiratory failure during hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of participants with cardiac arrest</measure>
    <time_frame>Two weeks</time_frame>
    <description>The sudden termination of cardiac ejection function, the disappearance of great artery pulsation and heart sound, and severe ischemia and hypoxia of important organs (such as brain) lead to the termination of life.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Length of stay</measure>
    <time_frame>Two weeks</time_frame>
    <description>Time between patient's visit and discharge</description>
  </other_outcome>
  <other_outcome>
    <measure>Rate of re-admitted participants</measure>
    <time_frame>Six months</time_frame>
    <description>Re-admission after discharge within 6 months</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Chest Pain</condition>
  <condition>Acute Aortic Dissection</condition>
  <condition>Pulmonary Embolism</condition>
  <condition>Acute Myocardial Infarction Type 1</condition>
  <condition>Acute Coronary Syndrome</condition>
  <arm_group>
    <arm_group_label>Acute chest pain</arm_group_label>
    <description>The population in this study are characterized by acute chest pain as the first symptom for consultation within 24 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Coronary angiography</intervention_name>
    <description>Acute chest pain patients, suspected acute coronary syndrome, are diagnosed by coronary angiography.</description>
    <arm_group_label>Acute chest pain</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>CT angiography of aorta</intervention_name>
    <description>Acute chest pain patients, suspected acute aortic dissection, are diagnosed by gold standard of CTA.</description>
    <arm_group_label>Acute chest pain</arm_group_label>
    <other_name>CTA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>CT angiography of pulmonary arteries.</intervention_name>
    <description>Acute chest pain patients, suspected acute pulmonary embolism, are diagnosed by gold standard of CTA.</description>
    <arm_group_label>Acute chest pain</arm_group_label>
    <other_name>CTA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Electrocardiogram</intervention_name>
    <description>All patients with acute chest pain will subject to ECG examination within 10 minutes of admission, which can quickly screen ST-segment elevation myocardial infarction.</description>
    <arm_group_label>Acute chest pain</arm_group_label>
    <other_name>ECG</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Cardiac Troponin</intervention_name>
    <description>Dynamic changes of cardiac troponin I and/or T will be used in the diagnosis of acute myocardial infarction</description>
    <arm_group_label>Acute chest pain</arm_group_label>
    <other_name>Biomarkers of myocardial injury</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood and plasma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The population in this study is characterized by acute chest pain as the first symptom for
        consultation. These are mainly Han and Tibetan patients from southwest China. The study
        population included first-visit and referral patients.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient aged 18-90 years old;

          -  The time from onset of symptoms to emergency room is less than 24 hours.

        Exclusion Criteria:

          -  Patients complicate with end-stage neoplastic diseases;

          -  Pregnant women;

          -  Patients re-visit during the selection period;

          -  Patients refuse to participate in this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dongze Li, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emergency Department, West China Hospital, Sichuan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dongze Li, MBBS</last_name>
    <phone>+86-28-85422461</phone>
    <email>dongze.li@ymail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yisong Cheng, MBBS</last_name>
    <phone>+86-19983154487</phone>
    <email>yisongcheng01@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Affiliated Hospital of Zunyi Medical University</name>
      <address>
        <city>Zunyi</city>
        <state>Guizhou</state>
        <zip>563000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Haizhen Duan, MD</last_name>
      <phone>+86-028-8649999</phone>
      <email>dhzh1027@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chengdu Second People's Hospital</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610021</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ling Li, MBBS</last_name>
      <phone>+86-028-67830120</phone>
      <email>117754652@qq.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chengdu Shangjin Nanfu Hospital</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610041</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rongsheng Du, MD</last_name>
      <phone>+86-028-62539407</phone>
      <email>793203755@qq.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sichuan Integrative Medicine Hospital</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610041</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jing Yu, MBBS</last_name>
      <phone>+86-028-63160059</phone>
      <email>yujing5126@foxmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>West China Hospital, Sichuan University</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610041</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dongze Li, MBBS</last_name>
      <phone>+86-28-85422461</phone>
      <email>dongze.li@ymail.com</email>
    </contact>
    <contact_backup>
      <last_name>Yu Jia, MBBS</last_name>
      <phone>+86-18080085361</phone>
      <email>453986149@qq.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>People's Hospital of Xindu District</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610500</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fangmin Fan, MBBS</last_name>
      <phone>+86-028-83993061</phone>
      <email>54907851@qq.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Affiliated Hospital of Southwest Medical University</name>
      <address>
        <city>Luzhou</city>
        <state>Sichuan</state>
        <zip>646099</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ying Liu, MD</last_name>
      <phone>+86-0830-3165851</phone>
      <email>liu61213@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Panzhihua Central Hospital</name>
      <address>
        <city>Panzhihua</city>
        <state>Sichuan</state>
        <zip>617000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhengli Luo, MBBS</last_name>
      <phone>+86-0812-2238148</phone>
      <email>878838423@qq.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zigong Fourth People's Hospital</name>
      <address>
        <city>Zigong</city>
        <state>Sichuan</state>
        <zip>643000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ping Xu, MD</last_name>
      <phone>+86-0813-2401126</phone>
      <email>58124453@qq.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>October 6, 2019</study_first_submitted>
  <study_first_submitted_qc>October 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 10, 2019</study_first_posted>
  <last_update_submitted>November 27, 2019</last_update_submitted>
  <last_update_submitted_qc>November 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>West China Hospital</investigator_affiliation>
    <investigator_full_name>Dongze Li</investigator_full_name>
    <investigator_title>Lecturer, Clinical Research</investigator_title>
  </responsible_party>
  <keyword>Chest pain</keyword>
  <keyword>Acute Aortic Dissection</keyword>
  <keyword>Pulmonary Embolism</keyword>
  <keyword>Acute Coronary Syndrome</keyword>
  <keyword>Acute myocardial infarction</keyword>
  <keyword>Risk stratification</keyword>
  <keyword>Prognosis</keyword>
  <keyword>Biomarkers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Embolism</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Embolism</mesh_term>
    <mesh_term>Aneurysm, Dissecting</mesh_term>
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Chest Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>This study will share individual participant data (IPD) including patient characteristics, vital signs, laboratory examinations, imaging examinations, diagnosis, adverse events in hospital and long-term prognosis.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Six months after completion of the test</ipd_time_frame>
    <ipd_access_criteria>IPD will be public accessable via Electronic Data Capture. (ResMan: http://www.medresman.org.)</ipd_access_criteria>
    <ipd_url>http://www.medresman.org</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

